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Epigenetic regulation, including histone modiﬁcation, is a critical component of gene regulation, although
precisely how this contributes to the development of complex tissues such as the neural retina is still being
explored. We show that during retinal development in mouse, there are dynamic patterns of expression of
the polycomb repressive complex 2 (PRC2) catalytic subunit EZH2 in retinal progenitors and some dif-
ferentiated cells, as well as dynamic changes in the histone modiﬁcation H3K27me3. Using conditional
knockout of Ezh2 using either Pax6-αCre or Six3-Cre, we ﬁnd selective reduction in postnatal retinal
progenitor proliferation, disruption of retinal lamination, and enhanced differentiation of several late born
cell types in the early postnatal retina, including photoreceptors and Müller glia, which are ultimately
increased in number and become reactive. RNA-seq identiﬁes many non-retinal genes upregulated with
loss of Ezh2, including multiple Hox genes and the cell cycle regulator Cdkn2a, which are established targets
of EZH2-mediated repression. ChIP analysis conﬁrms loss of the H3K27me3 modiﬁcation at these loci.
Similar gene upregulation is observed in retinal explants treated with an EZH2 chemical inhibitor. There is
considerable overlap with EZH2-regulated genes reported in non-neural tissues, suggesting that EZH2 can
regulate similar genes in multiple lineages. Our ﬁndings reveal a conserved role for EZH2 in constraining
the expression of potent developmental regulators to maintain lineage integrity and retinal progenitor
proliferation, as well as regulating the timing of late differentiation.
& 2015 Elsevier Inc. All rights reserved.Introduction
During the development of complex tissues, the balance
between proliferation and differentiation of progenitors, and the
timing of differentiation is critical to ensure that various cell types
are generated in appropriate numbers. The dramatic changes in
gene expression driving these events are regulated primarily by
transcription factors that are expressed in stage and cell-type
dependent manner. This has been well deﬁned in the developing
neural retina, where speciﬁc sets of transcription factors deﬁne
retinal progenitor identity and regulate the ordered genesis of
distinct retinal cell types (Bassett and Wallace, 2012). But there is
increasing evidence that in many systems epigenetic regulation,and Anatomy, University of
401 MREB, Salt Lake City, UT
.L. Vetter).such as histone modiﬁcation, also plays an important role. These
modiﬁcations can serve as gatekeepers for the activity of tran-
scription factors, and thus regulate gene activation or repression
(Laugesen and Helin, 2014). While the molecular machinery
involved in histone modiﬁcations have been well studied, their
precise roles during in vivo development are still being explored.
One of the key repressive modiﬁcations is the trimethylation of
lysine 27 on histone H3 (H3K27me3). The di- and tri-methylation
of H3K27 is primarily catalyzed by polycomb repressive complex 2
(PRC2), with the enzymatic activity of the complex mediated by
the subunit Enhancer of zeste 2 (EZH2), and in some instances by
EZH1 (Margueron and Reinberg, 2011). Polycomb group proteins
were originally identiﬁed in Drosophila for their role in silencing
Hox genes (Schuettengruber et al., 2007), but are now recognized
to have broader roles in both invertebrate and vertebrate devel-
opment, including neural development (Aldiri and Vetter, 2012;
Margueron and Reinberg, 2011). In embryonic stem cells (ESCs)
PRC2 is required for neural differentiation (Pasini et al., 2007; Shen
J. Zhang et al. / Developmental Biology 403 (2015) 128–138 129et al., 2008), and PRC2 targets many of the genes involved in
neurogenesis for H3K27me3 modiﬁcation (Boyer et al., 2006; Lee
et al., 2006).
The in vivo role of Ezh2 during neural development is complex.
During the late phase of neocortical development PRC2 cooperates
with PRC1 to restrict the generation of neurons to allow astrocyte
production, with Ezh2 conditional knockouts showing a prolonged
neurogenic phase (Hirabayashi and Gotoh, 2010; Hirabayashi et al.,
2009). In contrast, early deletion of Ezh2 in the developing cerebral
cortex causes enhanced early neurogenesis, accompanied by earlier
astrocyte production and a premature termination of cell pro-
liferation (Pereira et al., 2010). Furthermore, knockdown of Ezh2 in
neural stem cell cultures also leads to a reduction in their pro-
liferation and self-renewal potential and enhanced production of
astrocytes rather than oligodendrocytes upon differentiation (Sher
et al., 2008). Interestingly, in the neural crest, Ezh2 is not required
for neural development (Schwarz et al., 2014). Thus, Ezh2 appears to
play complex roles in the developing nervous system, and can
promote or block differentiation, maintain proliferation, and/or
regulate the timing of cell fate acquisition. These diverse develop-
mental roles have also been ascribed to Ezh2 function in other tis-
sues, including skin, skeletal muscle, heart and lung (Ezhkova et al.,
2009; He et al., 2012; Juan et al., 2011; Snitow et al., 2015; Wood-
house et al., 2013). However, it is unclear whether core molecular
mechanisms are responsible for these functions in multiple tissues.
The developing neural retina is an excellent system to investi-
gate this question, since progenitor properties and the transcrip-
tional regulation of cell fate determination are well described
(Bassett andWallace, 2012). Furthermore, genome-wide H3K27me3
histone modiﬁcation has been characterized at several key stages of
mouse retinal development (Popova et al., 2012). In Xenopus, we
previously found that knocking down or blocking the PRC2 core
component Ezh2 reduces retinal neurogenesis and promotes Müller
glial cell differentiation (Aldiri et al., 2013). We also observed
reduced retinal progenitor proliferation, in part due to upregulation
of the Cdk inhibitor p15 (Ink4b; Cdkn2b), which is a direct target of
EZH2-mediated repression in multiple tissues (Popov and Gil, 2010).
Conditional disruption of Ezh2 in the mouse retina using Dkk-Cre
showed that Ezh2 is also required to repress cdkn2a and maintain
progenitor proliferation and the normal timing of retinal differ-
entiation (Aldiri et al., 2013; Iida et al., 2014).
However, we lack a detailed understanding of the molecular
changes associated with loss of PRC2-mediated repression in the
developing retina and how this relates to PRC2 function in other
tissues. We performed conditional disruption of Ezh2 in the mouse
retina using Pax6-αCre, and assessed effects on retinal develop-
ment as well as gene expression changes by RNAseq. Our analysis
shows that Ezh2 and its repressive histone modiﬁcations are
necessary to maintain the transcriptional identity as well as pro-
liferation state of retinal progenitors, to regulate proper timing of
differentiation during early postnatal retinal development, and to
constrain the generation of Müller glia.Materials and methods
Ezh2ﬂ/ﬂ, Pax6-αCre and R26EYFP mice and their genotyping have
been described previously (Marquardt et al., 2001; Shen et al., 2008;
Srinivas et al., 2001; Su et al., 2003). Mouse breeding details are pro-
vided in SI Materials and methods. For immunostaining, retinal sec-
tions were generated as previously described (La Torre et al., 2013).
Nuclear counterstain was done using either DAPI or Hoechst. Detailed
methods and antibodies used are listed in SI Materials and methods.
In situ hybridization was performed on whole embryos and retinal
sections using digoxigenin (DIG)-labeled riboprobe for mouse Ezh2, as
previously described (Zhang et al., 2008). Hematoxylin and eosinstaining of retinal sections was performed as previously described
(Zhang et al., 2008). For explant culture, retinas from E14 mouse
embryos were dissected and cultured as previously described (La Torre
et al., 2013) with GSK126 (Xcess Biosciences) added at 2 μM or 10 μM,
and corresponding concentrations of vehicle (DMSO) added to the
control samples.
For RNAseq analysis the peripheral one-third of E16.5 retinas
was dissected, left and right eyes combined, and total RNA isolated
using RNeasy Plus Mini Kit according to manufacturer’s protocol
(Qiagen). RNA integrity was conﬁrmed using a Bioanalyzer RNA
6000 Nano Chip. Four biological replicates of Ezh2ﬂ/ CKO animals
and Ezh2ﬂ/þ controls from the same litter were used for RNA
sequencing on a 50 bp single-end run on Illumina HiSeq 2000. See
SI Materials and methods for details. RNAseq data have been
deposited to the Gene Expression Omnibus repository (http://www.
ncbi.nlm.nih.gov/geo/) under series accession number GSE65082.
Primers for PCR and ChIP are listed in Supplemental Table 7.
Detailed methods for RNA isolation, RT-PCR and quantitative RT-
PCR are described in SI Materials and methods. For chromatin
immunoprecipitation (ChIP) analysis, the peripheral one-third of
postnatal day 0 retinas were dissected and processed, as described
in SI Materials and methods. Values were averaged from 3 biolo-
gically independent experiments and normalized for ChIP efﬁ-
ciency across biological replicates.Results
Ezh2 is dynamically expressed during retinal development
In the developing Xenopus retina, Ezh2 is enriched in retinal
progenitors and downregulated in differentiated cells (Aldiri et al.,
2013). To determine where Ezh2 is expressed during mouse retinal
development we performed in situ hybridization and found
expression in progenitor cells throughout the optic cup at e9.5
(Fig. 1A), and in retinal progenitors at e12.5 (not shown). Expres-
sion was reduced in the emerging retinal ganglion cell layer (GCL)
at e14.5, but maintained in retinal progenitors (Fig. 1B). By P0,
Ezh2 expression was evident in the GCL, as well as in the neuro-
blastic layer (Fig. 1C), and by P10 Ezh2 expression was largely
restricted to the GCL and inner nuclear layer (INL). Thus Ezh2 is
enriched in both retinal progenitors and subsets of differentiating
cells, with dynamic changes in expression over the course of
development.
Loss of Ezh2 results in impaired retinal development
To assess the function of Ezh2 during retinal development, we
conditionally inactivated Ezh2 in retinal progenitors by crossing
Pax6-αCre mice with either Ezh2ﬂ/ﬂ or Ezh2ﬂ/ mice (Shen et al.,
2008; Su et al., 2003). The Pax6-αCre retinal driver promotes
recombination in the peripheral retina from E10.5 onwards, which
is at the onset of retinal neurogenesis (Marquardt et al., 2001). By
immunostaining retinal sections at P3, EZH2 protein was detected
at high levels through the neuroblastic layer and at lower levels in
the GCL in peripheral retina of control Ezh2ﬂ/þ ::Pax6-αCre (Ezh2ﬂ/þ)
mice, with mosaic loss of EZH2 protein in Ezh2ﬂ/ﬂ::Pax6-αCre
(Ezh2ﬂ/ﬂ CKO) retina, that was more extensive in Ezh2ﬂ/::Pax6-αCre
(Ezh2ﬂ/ CKO) retina (Fig. 1E–G). In addition, H3K27me3 labeling
was enriched in the GCL and in the inner part of the neuroblastic
layer at P3 in Ezh2ﬂ/þ control retina (Popova et al., 2012), but
showed mosaic loss in Ezh2ﬂ/ﬂ CKO retina, that was more extensive
in Ezh2ﬂ/ CKO retina (Fig. 1H–J). When crossed with R26EYFPmice,
the reporter showed mosaic expression that corresponded to the
areas with loss of H3K27me3 (Supplemental Fig. 1).
Fig. 1. Ezh2 expression during retinal development and after Ezh2 conditional deletion. (A–D) In situ hybridization (ISH) analysis. (E–G) EZH2 immunostaining shows
increasing loss of protein in the peripheral retina with conditional deletion using Pax6-αCre in Ezh2ﬂ/ﬂ and Ezh2ﬂ/ mice relative to control Ezh2ﬂ/þ mice at P3. (E’-G’) Hoechst
staining of the same sections. (H–J) Similarly H3K27me3 immunostaining shows increasing loss of this histone mark. (H’-J’) Hoechst staining of the same sections. (K–M)
Hematoxylin and eosin staining shows increasing disruption to retinal lamination with conditional deletion using Pax6-αCre in Ezh2ﬂ/ﬂ and Ezh2ﬂ/ mice relative to control
Ezh2ﬂ/þ mice at P3. (N) Similar disruption of retinal lamination in the central retina is observed after conditional deletion of Ezh2 using Six3-Cre in Ezh2ﬂ/ mice. Scale
bar¼100 μm.
Fig. 2. Ezh2 deletion results in reduced retinal progenitor proliferation. (A–C) Increasing loss of Ki67 labeling (green) in the peripheral retina in Ezh2ﬂ/ﬂ and Ezh2ﬂ/ CKO mice
relative to control Ezh2ﬂ/þ mice at P3. (D–F) Similarly, there is increasing reduction of pH3 labeling (red), and (G–I) reduced labeling for the progenitor marker Vsx2 (green).
Scale bar¼100 μm.
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phenotype with Ezh2ﬂ/ versus Ezh2ﬂ/ﬂ CKO, we analyzed the
phenotype in both to assess effects on retinal development.
Hematoxylin and eosin staining of P3 retinal sections revealed
disruption of retinal lamination and reduced thickness of the
neuroblastic layer in Ezh2ﬂ/ﬂ CKO mice, that was more extensive in
Ezh2ﬂ/ CKO mice (Fig. 1K–M). For Ezh2ﬂ/ﬂ CKO mice, the R26EYFP
reporter conﬁrmed that the phenotype corresponded to the areas
of Cre-mediated recombination (Supplemental Fig. 1). We also
conﬁrmed disruption of retinal lamination that was restricted to
the central retina region in Ezh2ﬂ/ CKO animals using Six3-Cre
(Fig. 1N), which drives recombination in retinal progenitors (Fur-
uta et al., 2000). Thus, Ezh2 is required for normal retinal
development.
Ezh2 is required to maintain late retinal progenitor proliferation
Reduced thickness of the neuroblastic layer suggested reduced
retinal progenitor number in Ezh2 CKO retina. Labeling of pro-
genitors with the proliferation marker Ki67 was reduced at P3 in
Ezh2ﬂ/ﬂ CKO mice and to a greater extent in Ezh2ﬂ/ CKO mice
(Fig. 2A–C). The reduction in proliferation was conﬁrmed by a
similar reduction of pH3 labeling, which marks progenitor cells at
the G2-M transition (Fig. 2D–F). We also found signiﬁcant reduc-
tion at P3 in the numbers of cells labeled for the progenitor markerFig. 3. Ezh2 deletion alters retinal ganglion cell and amacrine cell numbers. (A,B) No cha
disruption of the RGC layer and reduced RGC number in Ezh2ﬂ/ﬂ and Ezh2ﬂ/ CKO retina r
Ezh2ﬂ/ CKO retina. N¼ 45 sections from 6 retinas. Error bars represent the standard erro
control Ezh2ﬂ/þ retina at P3 in Ezh2ﬂ/ﬂ CKO, but reduced in Ezh2ﬂ/ CKO. (J–L) Similarly,
cells is expanded in Ezh2ﬂ/ﬂ CKO, but reduced in Ezh2ﬂ/ CKO retina relative to control
Ezh2ﬂ/ CKO but not Ezh2ﬂ/ﬂ CKO retina relative to control Ezh2ﬂ/þ . N¼24, 24 and 27 se
represent the standard error, **¼Po0.001 Student’s t-test. Scale bar¼100 μm.Vsx2 in Ezh2ﬂ/ﬂ CKO mice that was more pronounced in Ezh2ﬂ/
CKO mice (Fig. 2G–I).
There was no effect on EdU labeling at e15 in Ezh2ﬂ/ﬂ CKO mice,
suggesting that the proportion of cells in S-phase was unaltered
(Supplemental Fig. 1). In addition, the proportion of cycling cells
appeared unchanged since there was no effect on PCNA labeling or
Ki67 labeling at e15.5 in Ezh2ﬂ/ CKO mice, although we cannot
rule out subtle effects on cell cycle length (Supplemental Fig. 1 and
data not shown). Although there was no apparent effect on retinal
progenitor proliferation, there was loss of EZH2 and H3K27me3
labeling of progenitors in the CKO region of the peripheral retina
at this stage (Supplemental Fig. 1). By P0 there was modest
reduction in Ki67 labeling in Ezh2ﬂ/ CKO mice, suggesting that
premature exit of progenitors has begun by this stage (Supple-
mental Fig. 1). Thus, we conclude that Ezh2 is required to maintain
proliferating progenitors during postnatal development, but not
embryonic retinal development.
Ezh2 deletion alters retinal ganglion cell and amacrine cell numbers.
Since disruption of Ezh2 has an effect on retinal progenitor
maintenance, we predicted that this would impact retinal cell fate
speciﬁcation. Retinal neurons in mouse are generated in a deﬁned
sequence beginning at e10.5 with retinal histogenesis largely
complete by postnatal day 14. An early wave of differentiation
during the embryonic period generates the majority of retinalnge in Brn3b labeling at e16.5 (green). (C–E) Brn3b immunostaining (green) shows
elative to control Ezh2ﬂ/þ at P3. (F) There is a 36% reduction in Brn3bþ cells at P3 in
r, **¼Po0.001 Student’s t-test. (G–I) Ap2þ amacrine cells are increased relative to
at P0 the GFP reporter that is expressed from the Pax6-αCre transgene in amacrine
Ezh2ﬂ/þ . (M) The number of cleaved caspase 3-positive cells is increased at P0 in
ctions from 6 retinas each, respectively for Ezh2ﬂ/þ , Ezh2ﬂ/ﬂ and Ezh2ﬂ/ . Error bars
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later postnatal wave generates the bulk of rod photoreceptors,
bipolar cells and Müller glia (Bassett and Wallace, 2012). We ﬁrst
assessed early born retinal neurons since we did not observe an
effect on proliferation during the embryonic period of retinal
neurogenesis. Consistent with this, there was no major effect on
Brn3b-positive RGCs at e15.5 in Ezh2ﬂ/ CKO mice (Fig. 3A and B).
But by P3 the numbers of Brn3b-labeled RGCs was signiﬁcantly
reduced in both Ezh2ﬂ/ and Ezh2ﬂ/ﬂ CKO retina (Fig. 3C–F). These
results suggest that although the ganglion cells are generated in
approximately normal numbers, these cells are reduced post-
natally (see below).
Amacrine cells are also largely born during the embryonic
period, so we investigated whether loss of Ezh2 affected this ret-
inal cell population. We observed an increase in Ap2-labeled
amacrine cells in Ezh2ﬂ/ﬂ CKO mice relative to Ezh2ﬂ/þ controls at
P3 (Fig. 3G and H). This was conﬁrmed by an increase in GFP-
labeled cells in Ezh2ﬂ/ﬂ CKO mice, since at postnatal stages the GFP
reporter from the Pax6-αCre transgene is expressed in amacrine
cells (Fig. 3J and K) (Marquardt et al., 2001). In contrast, there was
a decrease in Ap2-labeled amacrine cells in Ezh2ﬂ/ CKO mice, asFig. 4. Ezh2 deletion increases rod photoreceptor differentiation in the early postnatal r
deletion in Ezh2ﬂ/ retina results in increased photoreceptor differentiation relative to c
extent of the undifferentiated region at the peripheral margin of the retina, which is redu
P3 as evident by the thickened ONL. (E,F) This is similarly observed in Ezh2ﬂ/ﬂ CKO retina
are reduced in Ezh2ﬂ/ CKO. (K,L) Bipolar cells are reduced in the Ezh2 CKO region at P14
Vsx1-postive cells at P14 in Ezh2ﬂ/ CKO retina. N¼10, 12 sections, 4 retinas each respe
Student’s t-test. Scale bar¼100 μm.well as a decrease in GFP-labeled cells at P3 (Fig. 3I and L). By P10,
Ap2-labeled amacrine cells were signiﬁcantly reduced in Creþ
regions in Ezh2ﬂ/ﬂ CKO retina, largely due to reduced number of
labeled cells in the INL (N¼3 retinas per genotype, 3 sections/
retina, Po0.01 by Student’s t-test), and were also clearly reduced
at P14 in Ezh2ﬂ/ CKO retina (data not shown). Thus we observe
distinct effects on amacrine cell number in Ezh2ﬂ/ versus Ezh2ﬂ/ﬂ
CKO mice, but in both cases the amacrine and ganglion cell layers
were disorganized and intermixed.
To determine whether the survival of the neurons was com-
promised from the loss in Ezh2, we labeled the retinas for cleaved
caspase 3. We observed an increase in the numbers of cells labeled
for cleaved caspase 3 at P0 in Ezh2ﬂ/ CKO mice (Fig. 3M). A small
subset of cleaved caspase 3 positive cells colabeled for Brn3b (data
not shown), indicating that an increase in cell death that may
partially account for the reduced number of early born cell types in
Ezh2ﬂ/ CKO animals. This increase in cell death was not evident at
P3 and was not signiﬁcant at either stage in Ezh2ﬂ/ﬂ CKO mice.
Thus, we conclude that Ezh2 is not required for the genesis of early
born neurons during the embryonic period but is ultimately
required for the normal complement of early retinal cell types.etina, and affects overall numbers of later born retinal cell types. (A,B) Conditional
ontrol Ezh2ﬂ/þ at P0 as detected by recoverin labeling (green). Bracket indicates the
ced in CKO animals. (C,D) Increased photoreceptor differentiation is also evident at
at P0, and (G,H) at P3 (recoverin, red). (I,J) By P14 recoverin-positive photoreceptors
as detected by Vsx1 labeling (green). (M) Cell counts show a signiﬁcant reduction in
ctively for Ezh2ﬂ/þ and Ezh2ﬂ/ . Error bars represent the standard error. *¼Po0.01
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in the early postnatal retina:
Since loss of Ezh2 results in reduced proliferation and pro-
genitor depletion at early postnatal ages, we assessed whether this
would affect the differentiation of later born cell types. We found
that there was increased expression of photoreceptor differentia-
tion markers in the peripheral retina of both Ezh2ﬂ/ and Ezh2ﬂ/ﬂ
CKO mice at early postnatal ages. At P0, recoverin labeling in the
outer nuclear layer (ONL) extended more peripherally in both
Ezh2ﬂ/ and Ezh2ﬂ/ﬂ CKO retina, suggesting that more progenitors
in this region were differentiating at this timepoint than normal
(Fig. 4A, B, E and F), with the average distance from the ciliary edge
to the ﬁrst recoverin labeling decreased by 40% in Ezh2ﬂ/ﬂ CKO
retina (76 μM) compared to Ezh2ﬂ/þ controls (126 μM) (N¼3,
Po0.01). Consistent with this, by P3 there was a thickened layer of
recoverin-labeled cells in both Ezh2ﬂ/ and Ezh2ﬂ/ﬂ CKO retina
(Fig. 4C, D, G and H). This was not simply due to derepression of
recoverin expression, since we also observed increased labeling forFig. 5. Ezh2 deletion enhances Müller glia differentiation and leads to reactivity. (A–C)
differentiation at P3 relative to control Ezh2ﬂ/þ retina as detected by Cralbp immunstain
CKO retina. (F) Counts of Lhx2–labeled cells show a 25% increase in Müller glia in Ez
respectively for Ezh2ﬂ/þ and Ezh2ﬂ/ . **¼Po0.001, Student’s t-test. (G,H) Müller glia at P
(G’,H’) Hoechst staining of the same sections. Scale bar¼100 μm. GCL¼ganglion cell laythe synaptic marker SV2 in the outer plexiform layer in Ezh2ﬂ/ﬂ
CKO retina compared to Ezh2ﬂ/þ controls, indicating that more
functional photoreceptors are present in the P3 Ezh2 CKO retina
(Supplemental Fig. 2). This is likely due to more cells exiting and
differentiating as photoreceptors at the earlier timepoint, but it is
also possible that the process of photoreceptor differentiation is
accelerated, or that retinal cell birthorder is altered.
However, by P14 the recoverin-labeled ONL was noticeably
thinner in Ezh2ﬂ/ CKO retina (Fig. 4I and J). The reduction in
proliferation in the postnatal retina, coupled with the reduced ONL
thickness suggests that the progenitor depletion ultimately leads
to an overall reduction in photoreceptor production. Consistent
with this, the number of cells labeled with the photoreceptor
progenitor marker Otx2 was reduced by P3 in Ezh2ﬂ/ﬂ CKO retina
(data not shown).
Although the loss in Ezh2 leads to an acceleration in the timing
of differentiation of photoreceptors in the postnatal retina, we did
not observe a similar premature expression of the bipolar cell
marker Vsx1 in Ezh2ﬂ/ CKO retina at P3, prior to the onset ofConditional deletion in Ezh2ﬂ/ﬂ and Ezh2ﬂ/ retina results in increased Müller glia
ing. (D,E) Lhx2 immunostaining at P14 shows an increase in Müller glia in Ezh2ﬂ/
h2ﬂ/ CKO retina relative to Ezh2ﬂ/þ controls. N¼20, 24 sections, 6 retinas each
14 in the Ezh2ﬂ/ CKO region become reactive and show increased GFAP expression.
er, INL¼ inner nuclear layer, ONL¼outer nuclear layer.
Fig. 6. RNA-Seq reveals signiﬁcant gene upregulation following conditional deletion of Ezh2. (A) Heat map representation of log 2 (avg FPKM) for the top thirty genes
differentially expressed by at least twofold in peripheral retina at e16.5 in Ezh2ﬂ/ CKO mice relative to control Ezh2ﬂ/þ mice. Genes with no expression are assigned an FPKM
value of 0.1. A color-coded log 2 scale is shown at the side of the heat map. (B) RT-PCR for a subset of these genes conﬁrms their upregulation following conditional deletion
of Ezh2 at both e16.5 and P0. (C) Quantitative RT-PCR analysis following treatment of retinal explants with GSK126, a small molecule inhibitor of EZH2, also shows
upregulation of many genes that increase in the Ezh2 CKO. (D) Chromatin immunoprecipitation (ChIP)-qPCR for H3K27me3 on a subgroup of genes that are upregulated after
Ezh2 deletion conﬁrms depletion of H3K27me3. The Engrailed1 promoter was also assayed as a gene that is not upregulated after Ezh2 deletion. *¼po0.05, **¼po0.01,
Students’ t-test.
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bipolar cell differentiation (data not shown). By P14, the number of
Vsx1 labeled bipolar cells was signiﬁcantly reduced in Ezh2ﬂ/ CKO
retina (Fig. 4K and L). Thus, the requirement for Ezh2 in the normal
timing of photoreceptor differentiation does not extend to all late
generated cell types.
Ezh2 disruption results in increased early Müller glia differentiation
Since blocking Ezh2 in the Xenopus retina results in increased
Müller glial cell differentiation (Aldiri et al., 2013), we assessed
whether these cells would be affected with loss of Ezh2 in the
mouse retina. We found that at P3 there was increased Müller glial
differentiation in the peripheral retina of both Ezh2ﬂ/ and Ezh2ﬂ/ﬂ
CKO mice as detected by CRALBP expression (Fig. 5A–C). This
increase was already evident at P0 (data not shown). By P14 there
was a 25% increase in Lhx2 positive Müller glia in the CKO region
in Ezh2ﬂ/ CKO retina as compared to Ezh2ﬂ/þ retina (Fig. 5D–F).
Consistent with this, at P10 there was also an expansion of Sox2-
labeled cells in the INL of Ezh2ﬂ/ﬂ CKO retina, suggesting an
increase in Müller glia (data not shown). However, at P14 in
Ezh2ﬂ/ CKO retina Müller glia were reactive, and showed sig-
niﬁcant disorganization and upregulation of GFAP (Fig. 5G and H).
Glutamine synthase, was signiﬁcantly downregulated, consistent
with Müller glia reactivity (data not shown). At P10 we found no
coexpression of NeuN, which labels neurons, and Id1, which labels
Müller glia, in the CKO region of Ezh2ﬂ/ﬂ retina, indicating that the
distinction between neuron versus glial identity is maintained
(data not shown). Thus, we conclude that Ezh2 is required to
constrain Müller glial cell differentiation, and to regulate the
timing of their genesis.
Ezh2 is required to inhibit the expression of many developmental
regulators and non-retinal genes
To understand the mechanisms underlying this retinal pheno-
type we sought to determine which genes are deregulated by loss
of Ezh2. We dissected peripheral retina tissue at e16.5 to enrich for
regions with loss of Ezh2, and then performed RNA-seq. This age is
prior to apparent changes in retinal development, since we sought
to identify gene expression changes that are directly due to loss of
Ezh2. A total of 232 genes were differentially expressed in Ezh2ﬂ/
CKO versus Ezh2ﬂ/þ control animals with a fold change cutoff of 2
(Abs log 241, po0.05), with the majority of genes upregulated
and only four signiﬁcantly downregulated, which is consistent
with the canonical function of EZH2 in promoting gene repression
(Supplemental Table 1).
Examination of the top 30 most highly upregulated genes
showed that most of them had either no or very low expression in
the control retina, but were signiﬁcantly upregulated in Ezh2ﬂ/
CKO retina (Fig. 6A). This included genes encoding many devel-
opmental regulators such as multiple Hox transcription factors
(15/30 top upregulated genes), transcription factors (e.g. Six1,
Pou3f3), signaling factors (e.g. Fgf4) and the cell cycle inhibitor
Cdkn2a. Cdkn2b was also upregulated (Supplemental Table 1). To
conﬁrm the results of our RNA-seq analysis we performed RT-PCR
for a subset of the most highly upregulated genes, Cdkn2a, Six1,
Sall1, Pou3f3, and Hoxb9 using RNA isolated from peripheral retina
tissue and found that these candidate genes were upregulated at
e16.5, consistent with our RNA-seq timepoint, as well as at P0,
when the retinal phenotype is apparent (Fig. 6B). To further con-
ﬁrm these ﬁndings, we sought to independently reduce EZH2
activity. E14 retinal explants were treated with the EZH2 chemical
inhibitor GSK126 at 2 μM or 10 μM for four days, then RNA iso-
lated and quantitative RT-PCR performed to assess fold change in
expression for Six1, Cdkn2a, Pou3f3, Sall1, Nﬁx, Hoxb2 and Hoxb7.There was signiﬁcant upregulation of Six1, Cdkn2a, Sall1, and
Hoxb7, particularly at the 10 μM concentration, although Pou3f3,
Nﬁx, and Hoxb2 were upregulated but not signiﬁcantly (Fig. 6C).
Many of these most highly upregulated genes are repressed via
EZH2 in other tissues, suggesting that EZH2 may target common
genes regardless of cell lineage. To further investigate this, we
compared our gene expression proﬁling data for e16.5 retina
(GSE65082), which is ectodermal in origin, to data available in the
GEO data repository for gene expression changes in other lineages
after loss of Ezh2 (http://www.ncbi.nlm.nih.gov/geo/). For exam-
ple, out of the 232 genes differentially expressed in our study, 40
were also signiﬁcantly increased in e12.5 cardiomyocytes, which is
mesodermal in origin (GSE29992; abs log 240.585, po0.05; (He
et al., 2012)). Similarly, 29 were also signiﬁcantly increased in
e14.5 lung, which is endodermal in origin (GSE66060; abs
log 240.585, po0.05; (Snitow et al., 2015)). Multiple genes or
gene families were upregulated in all three datasets, including
Cdkn2a, Hox genes and Pou3f3 (Supplemental Table 2). While some
genes are upregulated in speciﬁc lineages, the fact that there is
such overlap suggests that Ezh2 is required to repress similar
classes of genes in multiple lineages, regardless of embryonic germ
layer origin.
We also compared the gene expression changes we found in
embryonic retina to those reported for adult tissues. An analysis of
gene expression from right ventricles of adult wild type and Ezh2-
deﬁcient hearts showed up to 60 genes common with our dataset
(GSE34274; Abs log 240.585, po0.05; (Delgado-Olguin et al.,
2012)). Of these, 18 genes were also upregulated in either e12.5
cardiomyocytes or e14.5 lung (Supplemental Table 3). This
includes the skeletal muscle gene Six1, which was among the most
highly upregulated in both lineages. This analysis strikingly shows
that overlapping genes are repressed in an Ezh2-dependent man-
ner regardless of lineage or developmental stage.
Many, but not all Ezh2 regulated genes have high levels of H3K27me3
To assess the link between H3K27me3 and retinal gene
expression changes in the Ezh2 CKO, we examined the genes that
are upregulated in the Ezh2 CKO and their levels of H3K27 tri-
methylation, as reported for the postnatal day 1 (P1) mouse retina
(Popova et al., 2012). Among the genes that are upregulated in the
Ezh2 CKO are those with the highest levels of H3K27me3 (Sup-
plemental Table 4). In order to conﬁrm that the conditional
knockout of Ezh2 results in depletion of H3K27me3, we performed
chromatin immunoprecipitation (ChIP) for this histone modiﬁca-
tion on a subgroup of these genes. The promoter regions (within
1 kb upstream of the transcription start site) of the upregulated
genes Hoxb2, Hoxb7, Pou3f3, Cdkn2a, Six1, Nﬁx were assayed for
H3K27me3 enrichment by ChIP-qPCR from Ezh2ﬂ/ﬂ CKO and
Ezh2ﬂ/þ littermates. The Engrailed1 promoter was also assayed as a
gene that is not upregulated after Ezh2 deletion. At all assayed
gene promoters, H3K27me3 levels were reduced, conﬁrming the
predicted effect of Ezh2 deletion (Fig. 6D). H3K27me3 levels were
reduced, but not absent, at least in part due to the incomplete
nature of the conditional deletion throughout the retina.
We found that H3K27me3 levels were reduced at the Engrailed1
promoter, although this gene is not upregulated following Ezh2
deletion. We identiﬁed additional genes that are most highly
marked with H3K27me3 in the P1 mouse retina, but that are not
signiﬁcantly increased in the Ezh2 CKO (Supplemental Table 5),
suggesting additional repressive mechanisms, or developmental
gain of H3K27me3 at P1 as compared to e16.5. Conversely, many
genes that increase in the Ezh2 CKO do not appear to have sig-
niﬁcant levels of H3K27me3 (Supplemental Table 6), suggesting
indirect regulation, or developmental loss of H3K27me3 by P1. An
important caveat is that different retinal cell types likely have
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which may not be detected by bulk analysis. Overall, we conclude
that EZH2 maintains repression of many potent developmental
regulators, including genes not normally expressed in the devel-
oping retina, although clearly other repressive mechanisms are also
involved in maintaining appropriate levels of gene expression in
retinal progenitors.Discussion
Development of the retina involves the ordered genesis of
distinct retinal cell types from proliferating retinal progenitors,
and by conditional deletion of Ezh2 in developing retina, we show
that Ezh2 plays multiple roles in the development of this tissue.
Ezh2 is required in postnatal retina to maintain progenitor pro-
liferation, coordinate the timing of differentiation and generate the
appropriate complement of late retinal cell types. In addition,
RNAseq analysis revealed that loss of Ezh2 results in upregulation
of cell cycle inhibitors and many non-retinal genes, indicating that
Ezh2 also maintains transcriptional integrity of cells in this lineage.
Genes upregulated after loss of Ezh2 in retina overlap signiﬁcantly
with those repressed by Ezh2 in other tissues of distinct devel-
opmental origin, suggesting that Ezh2 may have a core function in
repressing the expression of potent developmental regulators and
cell cycle genes regardless of lineage.
Loss of Ezh2 disrupts H3K27me3 in the developing retina
We observed that Ezh2 is highly expressed in retinal progeni-
tors and weakly in postmitotic cells of the inner retina, consistent
with previous studies showing signiﬁcant expression in pro-
liferating cells and embryonic tissues of multiple lineages,
including retina (Aldiri et al., 2013; Aldiri and Vetter, 2012; Ezh-
kova et al., 2009; Iida et al., 2014; Margueron et al., 2008). Iida
et al. (2014) showed EZH2 protein localized to Pax6-positive ret-
inal progenitors and RGCs at embryonic stages, while postnatally
EZH2 localized to glutamine synthase-positive Müller glia. In our
study, conditional deletion of Ezh2 in retinal progenitors resulted
in a large decrease in the level of H3K27me3 in the deleted region,
particularly in progenitors. The presence of residual H3K27me3,
particularly in some postmitotic cells, suggests potential con-
tribution by Ezh1, which is generally more highly enriched in
postmitotic cells and adult tissues than Ezh2 (Ezhkova et al., 2009;
Margueron et al., 2008). However, the expression and function of
Ezh1 in the developing retina remains to be determined.
We also noted increasing penetrance of phenotype, as well as
loss of Ezh2 and H3K27me3, when comparing Ezh2ﬂ/ﬂ versus
Ezh2ﬂ/ CKO retina using the Pax6-αCre driver (Marquardt et al.,
2001). Thus, the recombination efﬁciency and/or differences in the
timing of deletion seem to impact the phenotype. We conﬁrmed
that the Ezh2ﬂ/ﬂ CKO phenotype was identical when generated by
either lab. In addition, the Ezh2 CKO phenotype was also apparent
using the Six3-Cre driver (Furuta et al., 2000), and has also
recently been reported using Dkk-Cre (Iida et al., 2014). Together
these ﬁndings demonstrate a consistent role for Ezh2 in the reg-
ulation of retinal development.
Ezh2 maintains retinal progenitor proliferation
One of the most highly conserved functions of Ezh2 in devel-
oping tissues is the maintenance of progenitor proliferation (Lau-
gesen and Helin, 2014). Similar to the ﬁndings of Iida et al., 2014,
we observed that loss of Ezh2 in retinal progenitors results in
reduced proliferation at early postnatal ages, as well as upregu-
lation of Cdkn2a (Arf/Ink4a) and Cdkn2b (Ink4b), which regulate theG1/S transition of the cell cycle and control of apoptosis. Both loci
are not normally expressed in the developing retina, and have high
levels of H3K27me3 histone modiﬁcation in newborn mouse
retina (Popova et al., 2012). It is likely that the proliferation defect
is due to premature cell cycle exit of retinal progenitors, as
demonstrated in the Xenopus retina (Aldiri et al., 2013), although
changes in cell cycle kinetics or progenitor cell death may also
contribute to progenitor depletion. In both Xenopus and mouse,
loss or inhibition of Ezh2 leads to an increase in Arf/Ink4a or Ink4b,
with ectopic expression of these genes causing reduced pro-
liferation (Aldiri et al., 2013; Iida et al., 2014). Cell cycle genes are
dysregulated in other regions of the CNS upon loss of Ezh2 (Pereira
et al., 2010). Deﬁciency of Ink4a/Arf was sufﬁcient to restore pro-
liferation in Ezh2-deﬁcient neural stem cells, demonstrating that it
is the principal factor resulting in loss of proliferation (Hwang
et al., 2014). Cdkn2a is a well-documented direct target for
repression by Ezh2 in many other tissues, and is also associated
with cancer (Popov and Gil, 2010). Thus maintaining proliferation
by preventing the expression of cell cycle inhibitors is a core
function of Ezh2.
Progenitor proliferation was unaffected by loss of Ezh2 in
embryonic retina, suggesting that additional mechanisms regulate
cell cycle gene expression. Consistent with this possibility, retinal
progenitor proliferation and cell cycle genes are also regulated by
G9a methyltransferase via H3K9 methylation (Katoh et al., 2012). It
is also possible that distinct mechanisms function during embryonic
versus postnatal development to regulate proliferation, since con-
ditional knockout of the DNA methyltransferase gene Dnmt1 also
alters cell cycle progression in postnatal but not embryonic retina
(Rhee et al., 2012).
Ezh2 maintains the timing of late retinal cell differentiation
Ezh2 deletion and the concomitant loss of H3K27me3 in the
developing retina caused striking alterations in histogenesis and
retinal lamination. Differentiation of retinal ganglion cells, an early
born cell type, was normal during the embryonic period, similar to
the effect on proliferation, although numbers were reduced by
early postnatal stages, potentially due to increased apoptosis.
Although we conﬁrmed loss of EZH2 and H3K27me3 embry-
onically, it is possible that other mechanisms act redundantly with
Ezh2 to ensure normal differentiation during the embryonic per-
iod. We observed increased differentiation for several late born
cell types at early postnatal ages, particularly rod photoreceptors
and Müller glia, similar to Iida et al. (2014). Although generated
early, by P14 rod photoreceptors were reduced in number,
potentially due to early cell cycle exit and progenitor depletion.
However, overall numbers of Müller glia were increased, sug-
gesting a shift from neuron to glial fate. In Xenopus, Ezh2 knock-
down also caused an increase in Müller glia differentiation at the
expense of neurons (Aldiri et al., 2013), possibly due to reduced
proneural gene expression, which we do not observe in our
RNAseq data. Instead we ﬁnd increased expression of the glial
gene Nﬁx, and Ink4a/Arf, both of which have been shown to reg-
ulate glial fate acquisition (Price et al., 2014; Wilczynska et al.,
2009).
Ezh2 regulates the timing of differentiation and the proportion
of cell types generated in multiple developmental contexts. In the
cerebral cortex after conditional Ezh2 deletion using Emx1-Cre,
there is an acceleration of developmental timing, with early onset
of gliogenesis, and a shift from self-renewal to differentiation in
cortical progenitors (Pereira et al., 2010). In contrast, conditional
deletion of Ezh2 during late corticogenesis results in an extended
period of neurogenesis and failure to switch to astrocyte produc-
tion (Hirabayashi et al., 2009). Thus the effects of Ezh2 loss on
developmental timing are highly context-dependent (Aldiri and
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also been reported for non-neural tissues; basal cells in the
developing lung epithelium appear earlier and in increased num-
bers upon loss of Ezh2 (Snitow et al., 2015). Thus Ezh2 may act to
regulate the timing of differentiation and the proportion of cell
types generated in multiple developmental contexts.
Not all late born cell types were affected, since there was no
evidence for increased early bipolar cell differentiation (see
also Iida et al. (2014)). In addition, in Ezh2ﬂ/ﬂ CKO retina there was
an increase in amacrine cell number, while in Ezh2ﬂ/ CKO retina,
amacrine cells were decreased, potentially due to increased
penetrance of the phenotype, resulting in distinct effects on timing
of differentiation or survival of these neurons. Overall, the gene
expression changes induced by loss of Ezh2 may selectively affect
the differentiation of a subset of retinal neurons, perhaps by
mimicking the effects of related endogenous developmental reg-
ulators with shared binding speciﬁcity.
Upregulation of non-retinal genes with loss of Ezh2
Several classes of genes appear to be particularly susceptible to
silencing by the H3K27me3 histone modiﬁcation. In addition to
cell cycle inhibitors, 24 Hox genes were upregulated in Ezh2ﬂ/
CKO retina, including multiple genes from the Hoxa, Hoxb and
Hoxc clusters, consistent with the Hox loci having some of the
highest levels of H3K27me3 in the P1 retina (Popova et al., 2012).
Hox genes are upregulated in many tissues upon loss of Ezh2,
including tissues with very different embryonic origin such as
cardiac tissue or lung endoderm (He et al., 2012; Snitow et al.,
2015). Such deregulation can have signiﬁcant developmental
consequences. For example, derepression of Hox genes in neural
crest cells, where they are not normally expressed, prevents cra-
niofacial bone and cartilage formation (Schwarz et al., 2014).
Polycomb genes were ﬁrst identiﬁed for their role in the regulation
of Hox genes in Drosophila, suggesting an ancient and strongly
conserved relationship between Hox gene regulation and H3K27
trimethylation (Sparmann and van Lohuizen, 2006).
We conﬁrmed that other potent developmental regulators are
upregulated in the Ezh2 CKO retina, including genes with high
levels of H3K27 trimethylation, such as Six1, Sall1, and Pou3f3,
which showed reduced H3K27me3 by ChIP analysis in the Ezh2
CKO retina. For all these genes the H3K27me3 modiﬁcation levels
are much higher than the levels of the permissive mark H3K4me2
in the P1 retina (Popova et al., 2012). However, unlike Iida et al.
(2014), we did not observe changes in the expression of bHLHb4,
Vsx1 or Isl1 (Iida et al., 2014).
Most of the upregulated genes are not signiﬁcantly expressed
during normal retinal development, consistent with a role for Ezh2
in repressing non-relevant gene programs to preserve lineage
integrity, as proposed for skeletal muscle stem cells (Conerly et al.,
2011; Juan et al., 2011). Comparing RNAseq and previous gene
proﬁling studies from embryonic and adult tissues of diverse
developmental origin, we ﬁnd that loss of Ezh2 in retina leads to
changes in expression of many of the same genes. While there are
lineage-speciﬁc changes in gene expression after loss of Ezh2,
many of these genes represent families of developmental reg-
ulators originally identiﬁed as PRC2 targets in embryonic stem
cells (Lee et al., 2006). Promoters of many developmental control
genes are poised for expression (Zeitlinger and Stark, 2010), and
bivalent domains in their promoter regions containing both per-
missive H3K4me3 and repressive H3K27me3 modiﬁcations have
been proposed to silence expression while keeping the genes
poised for activation, which can be triggered by loss of H3K27me3
(Voigt et al., 2013). While bivalent domains can be dynamically
modiﬁed, it is intriguing to consider that for a core set of genes this
poised state may be maintained across lineages and into adulttissues (Weishaupt et al., 2010). Since H3K4me3 was not assessed
here, it remains to be determined whether such bivalent domains
are present in the developing mouse retina, and whether there is
variation among the heterogeneous cell populations that are pre-
sent in this tissue.
H3K27me3 levels do not strictly correspond to gene expression
changes after loss of Ezh2
Not all genes with high levels of H3K27me3 were upregulated in
the Ezh2 CKO retina. For example, RNAseq analysis showed that no
Hoxd genes were upregulated, although Hoxd genes have high levels
of H3K27me3 in the newborn mouse retina (Popova et al., 2012),
and are known targets for PRC2-mediated repression. For example,
in human cells the Hoxd locus is speciﬁcally targeted for PRC2-
mediated repression via the long non-coding RNA HOTAIR (Rinn
et al., 2007). Other genes, including developmental regulators such
as Pax3, En1 and Olig2, are also highly marked with H3K27me3 in
the P1 mouse retina (Popova et al., 2012), but were not upregulated
with loss of Ezh2 in the retina. These data suggest that either other
repressive histone modiﬁcations are present at these loci, or that
the transcription factors necessary for their activation are not pre-
sent in the retina. In contrast to retina, after loss of Ezh2 from adult
mouse neural stem cells, Olig2 is upregulated and prevents neuro-
nal differentiation (Hwang et al., 2014), suggesting context-depen-
dent regulation of gene repression at certain loci.
Some genes that increase in the Ezh2 CKO do not appear to
have signiﬁcant levels of H3K27me3, although we cannot rule out
cell type-speciﬁc epigenetic regulation (Popova et al., 2014), which
can result in different levels of these modiﬁcations. Alternatively,
these genes may not be directly regulated by Ezh2, but may be
regulated by one of the many transcription factors that are dere-
pressed directly.
Chromatin modiﬁcations and regulation of retina development
Together with previous studies, our results show that different
sets of developmental genes are repressed by distinct com-
plementary epigenetic regulators. Two other well-established
repressive chromatin modiﬁcations, H3K9me2 and DNA methyla-
tion, are also required for retinal progenitor proliferation and/or
differentiation, involving genes that are different from those
regulated by Ezh2 (Katoh et al., 2012). Many long non-coding RNAs
(lncRNAs) interact with PRC2 to coordinate gene silencing
(Brockdorff, 2013), and several lncRNAs are expressed in retina and
regulate retinal neurogenesis (Meola et al., 2012; Rapicavoli et al.,
2010; Rapicavoli et al., 2011). In addition, we found signiﬁcant
upregulation of the PRC1 component Bmi1 in Ezh2 CKO retina.
Bmi1 has also been implicated in the regulation of proliferation
and differentiation in the developing nervous system (Fasano,
2009; Zencak et al., 2005). Thus, multiple repressive complexes are
required to coordinate retinal neurogenesis, and there is the
potential for cross-talk and complementary interactions in the
regulation of different repressive complexes during development.Acknowledgments
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